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635Assessment of Lung Ultrasound
Artifacts (B-Lines)
Incremental Contribution to
Echocardiography in Heart Failure?
We read with a great interest the paper by Miglioranza et al. (1),
which sought to deﬁne the performance of lung ultrasound (LUS)
compared with a clinical congestion score, natriuretic peptides, and
echocardiography, to evaluate decompensation in patients with
systolic heart failure (HF) in an outpatient clinic. This paper is a
valuable effort to bridge the gap between echocardiography and
thoracic ultrasound, and their separate skills and applicationda
topic that is still quite controversial (2).
Nonetheless, we remain skeptical about the value of this test.
Four methodological observations seem relevant. First, the speci-
ﬁcity of LUS B-lines is suboptimal: in addition to pulmonary
congestion, these are visible in chronic obstructive pulmonary dis-
ease (3), pulmonary ﬁbrosis (4), and lymphangitis (2,4). Second, the
evaluation process is at best semiquantitative, because the method is
more of a subjective overview than an actual “measurement.” Third,
most reference studies have used linear or convex probes rather than
phased array transducers; the use of phased-array transducers pro-
vides a greater risk of artifacts, depending on machine settings and
particularly at lower frequencies. Finally, the actual interobserver and
intraobserver measurement range is not reported (1).
There are also some practical issues that warrant further atten-
tion. First, although the authors state that “this technique is faster to
perform, is less expensive, and has lower technical requirements
compared with a full echocardiography examination,” such a com-
parison of cost and return needs formal study. Second, the statement
“LUS could be used as an extension of the physical examination and
to differentiate hemodynamic from pulmonary congestion” warrants
examination in a mixed patient group with pulmonary disease, to
truly evaluate the ability to perform this differentiation. Third, in
our opinion, the implication of the article that pharmacological
therapy could be tailored as soon as the patient, although asymp-
tomatic, shows a signiﬁcant increase in the number of B-lines is
speculative and not yet supported by solid evidence.
In conclusion, we think that a critical reappraisal of this and other
similar papers published on B-lines is mandatory. The evaluation of
these artifacts using subjective scores is contrary to efforts to improve
the reliability and objectivity of imaging (3–5).
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B-Lines: To Count
or Not to Count?
We found the paper by Miglioranza et al. (1) interesting and useful
for routine clinical practice because their purpose is that of simpli-
fying and obtaining from an ultrasound B-line count a measure of
lung water, a “measure” of disease, that would be approachable by
all, with a short period of training. Some points, though, need to be
clariﬁed because, unfortunately, the concept of B-line is not just that.
The investigators deﬁne B-lines according to a consensus state-
ment in which only a “qualitative” description is provided without any
explanation of their origin (2), which is still debated in the literature
(3). We know from past studies that these artifacts are an expression
of an error of the ultrasound machine in interpreting acoustic in-
teractions, so we do not agree that a simple “count” of B-lines could
be an “unambiguous” measure of extravascular lung water (EVLW),
because an increase in EVLW is not the sole origin of these artifacts.
In the study (1), to rule out false positives, only patients with a prior
diagnosis of pulmonary ﬁbrosis were excluded. But B-lines are found
in many other pulmonary conditions, such as pneumonia, atelectasis,
acute lung injury/acute respiratory distress syndrome, pleural disease,
and actually any ground-glass opacity seen in CT scans. They are
a very sensitive but, unfortunately, a very nonspeciﬁc sign. Is it,
with this optic, possible to “count” an ambiguous phenomena, with
debated and artifactual origin, to deﬁne a “cutoff” parameter related to
EVLW in decompensated congestive heart failure? Other authors are
pushing in this direction, and recently, Brattain et al. (4) have tested
portable sonography with an algorithm to count and formulate a score
of EVLW.Although promising, we would like to advise practitioners
to be on guard on this subject because the risk of underestimating a
problem by simplifying it is, yes, attractive, but could have serious
clinical implications (i.e., when mechanically ventilating a patient in
the intensive care unit: the origin of disease cannot be overseen).
In the study, in all but 2 patients, lung ultrasound was performed
in the anterolateral surface of each hemithorax, following interna-
tional recommendations (2), whereas the chest x-ray was always
carried out in orthostatism. We know how water distribution in
pulmonary congestion tends to accumulate in the posteroinferior,
antigravitational regions: why not use the same position? Was there
a difference between the 2 approaches?
Moreover, the investigators use a cardiac probe (2.5 to 3.5 MHz),
although it is to date common knowledge in the ﬁeld that the
number and features of B-lines change when examined with
different probes and at different angles of assessment (5). What
would be the best probe setting to carry out a repeatable count with
the least interoperator variability?
In conclusion, the description of extension (focal/bilateral),
localization, involvement (homogeneous/dishomogeneous), and
